Iterum Therapeutics
ITRM
$1.53
Share price
-0.65%
Change (1 day)
31.90%
Change (1 year)
Categories
Iterum Therapeutics (ITRM) - Cash on Hand
Cash on Hand as of December 2023 : $23.93 M
According to Iterum Therapeutics's latest financial reports the company has $23.93 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Iterum Therapeutics - Cash on Hand chart (from 2017 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $60.83 M | -25.24% |
| 2021-12-31 | $81.38 M | 382.46% |
| 2020-12-31 | $16.86 M | 251.34% |
| 2019-12-31 | $4.8 M | -94.32% |
| 2018-12-31 | $84.55 M | 115.6% |
| 2017-12-31 | $39.21 M | 58.07% |
| 2016-12-31 | $24.8 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 769.98% | 🇺🇸 USA |